Clinical trial NCT06382623: Efficacies of Different Managements in Patients With Trigger Finger
Official title: Comparing the Effectiveness of Peritendinous Steroid Injection Under Ultrasound Guidance With Percutaneous A1 Pulley Release in Trigger Finger Treatment
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Trigger Finger
Lead sponsor: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Sponsor class: OTHER
First posted: 2024-04-24
Enrollment: 30
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: older 18 ages

Brief summary: The aim of the study is to compare the effectiveness of peritendinous steroid injection under ultrasound guidance and percutaneous A1 pulley release procedures in terms of disease stage, pain, and severity of locking in patients with trigger finger.

Detailed description: This study was designed as a randomized, controlled, prospective study. Patients who had been experiencing trigger finger symptoms for at least one month and who presented to the Gaziler Physical Medicine and Rehabilitation Training and Research Hospital, affiliated with the Health Sciences University Faculty of Medicine

Patients were randomly divided into two groups: the peritendinous steroid group (n=15) and the percutaneous pulley release group (n=15). In the first group, under ultrasound guidance, a mixture of 1 ml corticosteroid (2 mg+5 mg/ml betamethasone) and 1 ml local anesthetic (20 ml 2% prilocaine) was injected peritendinously between the A1 pulley and the flexor tendon sheath. In the second group, a percutaneous A1 pulley release procedure was performed under ultrasound guidance using a 20 G needle, followed by peritendinous injection of the same mixture of corticosteroid and local anesthetic.

Patients were evaluated four times: before treatment, at 1 week, 1 month, and 3 months after treatment. Modified Quinnel classification, VAS (Visual Analog Scale), and severity of locking scales were used as outcome measures in the study.

Eligibility criteria: Inclusion Criteria:

* Being over 18 years of age
* Having had trigger finger complaints for more than 1 month
* Not having received any injections for trigger finger diagnosis within the last 1 month
* Signing the informed consent form indicating willingness to participate in the study

Exclusion Criteria:

* Refusing to participate in the study
* Presence of partial or complete tendon rupture in the relevant tendon of the finger to be treated
* Presence of wounds and infection in the area where the procedure will be performed
* Pregnancy status
* History of allergy to the injected medications (local anesthetic, steroid)

Primary outcomes:
measure: Stage of the disease
timeFrame: first week, first mount, third month
Secondary outcomes:
measure: Pain intensity
timeFrame: first week, first month, third month
measure: severity of triggering
timeFrame: first week, first month, third month
Other outcomes:
Locations:
city: Ankara
country: Turkey
facility: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Study officials:
affiliation: university of health sciences, Department of PM&R
name: zeliha gizem mac, MD
role: PRINCIPAL_INVESTIGATOR
References: